• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?

作者信息

Nabatchikova Ekaterina, Abdurakhmanov Dzhamal, Rozina Teona, Nikulkina Elena, Tanaschuk Elena, Moiseev Sergey

机构信息

The Department of Internal, Occupational Diseases and Rheumatology, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow, 119991, Russia.

The Department of Internal, Occupational Diseases and Rheumatology, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow, 119991, Russia.

出版信息

J Hepatol. 2020 Aug;73(2):469-470. doi: 10.1016/j.jhep.2020.03.035. Epub 2020 Jun 1.

DOI:10.1016/j.jhep.2020.03.035
PMID:32498974
Abstract
摘要

相似文献

1
Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?
J Hepatol. 2020 Aug;73(2):469-470. doi: 10.1016/j.jhep.2020.03.035. Epub 2020 Jun 1.
2
Reply to: "Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?" and "External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals".回复：“丙型肝炎病毒根除后的肝细胞癌监测：肝脏硬度测量是否比实验室纤维化标志物更有用？”以及“口服抗病毒药物后丙型肝炎病毒相关性晚期慢性肝病患者肝细胞癌非侵入性预测指标的外部验证”
J Hepatol. 2020 Aug;73(2):472-473. doi: 10.1016/j.jhep.2020.04.023. Epub 2020 Jun 1.
3
The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma.
J Formos Med Assoc. 2021 Apr;120(4):1160. doi: 10.1016/j.jfma.2020.11.012. Epub 2020 Dec 5.
4
Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.丙型肝炎病毒1b型、肝硬化和肝细胞癌。
Hepatology. 1997 Mar;25(3):772-4. doi: 10.1002/hep.510250347.
5
Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.组织病理学改善停滞是丙型肝炎病毒清除后肝细胞癌发展的预测因子。
PLoS One. 2018 Mar 13;13(3):e0194163. doi: 10.1371/journal.pone.0194163. eCollection 2018.
6
Response to letter to the editor "The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma".对致编辑信《直接抗病毒药物清除丙型肝炎病毒后细胞因子变化对肝细胞癌风险的影响》的回复
J Formos Med Assoc. 2021 Apr;120(4):1161-1164. doi: 10.1016/j.jfma.2020.12.016. Epub 2020 Dec 24.
7
The relationship between hepatocellular carcinoma and hepatitis B and C virus.肝细胞癌与乙型和丙型肝炎病毒之间的关系。
Clin Adv Hematol Oncol. 2016 Feb;14(2):96-8.
8
Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.丙肝病毒经干扰素治疗清除后肝细胞癌的发生
West J Med. 1997 Aug;167(2):103-5.
9
Surveillance for hepatocellular carcinoma after hepatitis C virus eradication.
Minerva Med. 2022 Jun;113(3):569-570. doi: 10.23736/S0026-4806.20.06496-4. Epub 2020 Mar 12.
10
The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.丙型肝炎治疗革命对肝细胞癌的影响。
Ann Oncol. 2016 Aug;27(8):1467-74. doi: 10.1093/annonc/mdw219. Epub 2016 May 25.

引用本文的文献

1
Hepatocellular Carcinoma After HCV Eradication with Direct-Acting Antivirals: A Reappraisal Based on New Parameters to Assess the Persistence of Risk.直接作用抗病毒药物根除丙型肝炎病毒后发生的肝细胞癌：基于评估风险持续性新参数的重新评估
Cancers (Basel). 2025 Mar 18;17(6):1018. doi: 10.3390/cancers17061018.
2
Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response.丙型肝炎：持续病毒学应答后至消除及残留肝脏和肝外病变的问题
World J Hepatol. 2022 Jan 27;14(1):62-79. doi: 10.4254/wjh.v14.i1.62.
3
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.
慢性丙型肝炎治愈后伴晚期纤维化或肝硬化患者的 HCC 发病率：一项荟萃分析。
Hepatology. 2022 Jul;76(1):139-154. doi: 10.1002/hep.32341. Epub 2022 Feb 7.